Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients
© 2015 Dustri-Verlag Dr. K. Feistle. Objective: Tenofovir is an efficacious drug with a long half-life and high activity against both HIV and HBV. However, the pharmacokinetics of tenofovir have not been studied in HIV/HBV co-infected patients. Data from HIV mono-infected patients may not be transfe...
Saved in:
Main Authors: | Baralee Punyawudho, Narukjaporn Thammajaruk, Parawee Thongpeang, Gail Matthews, Sharon R. Lewin, David Burger, Kiat Ruxrungtham, Anchalee Avihingsanon |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84946720638&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/44118 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients
by: Baralee Punyawudho, et al.
Published: (2018) -
Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients
by: Kanokrat Rungtivasuwan, et al.
Published: (2018) -
Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients
by: Kanokrat Rungtivasuwan, et al.
Published: (2018) -
Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients
by: Kanokrat Rungtivasuwan, et al.
Published: (2018) -
Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
by: Baralee Punyawudho, et al.
Published: (2018)